Standard
Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis. / Grint, Daniel; Peters, Lars; Rockstroh, Juergen K; de Wit, Stephane; Mitsura, Victor M; Knysz, Brygida; Pedersen, Court; Kirk, Ole; Lundgren, Jens D; Mocroft, Amanda; EuroSIDA in EuroCoord.
I:
AIDS (London, England), Bind 28, Nr. 4, 20.02.2014, s. 577-587.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Grint, D, Peters, L, Rockstroh, JK, de Wit, S, Mitsura, VM, Knysz, B, Pedersen, C
, Kirk, O, Lundgren, JD, Mocroft, A & EuroSIDA in EuroCoord 2014, '
Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis',
AIDS (London, England), bind 28, nr. 4, s. 577-587.
https://doi.org/10.1097/QAD.0000000000000069
APA
Grint, D., Peters, L., Rockstroh, J. K., de Wit, S., Mitsura, V. M., Knysz, B., Pedersen, C.
, Kirk, O., Lundgren, J. D., Mocroft, A., & EuroSIDA in EuroCoord (2014).
Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis.
AIDS (London, England),
28(4), 577-587.
https://doi.org/10.1097/QAD.0000000000000069
Vancouver
Grint D, Peters L, Rockstroh JK, de Wit S, Mitsura VM, Knysz B o.a.
Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis.
AIDS (London, England). 2014 feb. 20;28(4):577-587.
https://doi.org/10.1097/QAD.0000000000000069
Author
Grint, Daniel ; Peters, Lars ; Rockstroh, Juergen K ; de Wit, Stephane ; Mitsura, Victor M ; Knysz, Brygida ; Pedersen, Court ; Kirk, Ole ; Lundgren, Jens D ; Mocroft, Amanda ; EuroSIDA in EuroCoord. / Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis. I: AIDS (London, England). 2014 ; Bind 28, Nr. 4. s. 577-587.
Bibtex
@article{8aba921d26a04699b2e918271da8324f,
title = "Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis",
abstract = "Most antiretroviral drugs are metabolized by the liver; hepatic disease or liver damage as a result of hepatitis C virus (HCV) could impair this metabolism leading to an increased risk of drug toxicity. This study aimed to determine the risk of antiretroviral drug discontinuation among HCV/HIV coinfected patients.",
author = "Daniel Grint and Lars Peters and Rockstroh, {Juergen K} and {de Wit}, Stephane and Mitsura, {Victor M} and Brygida Knysz and Court Pedersen and Ole Kirk and Lundgren, {Jens D} and Amanda Mocroft and {EuroSIDA in EuroCoord}",
year = "2014",
month = feb,
day = "20",
doi = "10.1097/QAD.0000000000000069",
language = "English",
volume = "28",
pages = "577--587",
journal = "AIDS",
issn = "1350-2840",
publisher = "Lippincott Williams & Wilkins, Ltd.",
number = "4",
}
RIS
TY - JOUR
T1 - Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis
AU - Grint, Daniel
AU - Peters, Lars
AU - Rockstroh, Juergen K
AU - de Wit, Stephane
AU - Mitsura, Victor M
AU - Knysz, Brygida
AU - Pedersen, Court
AU - Kirk, Ole
AU - Lundgren, Jens D
AU - Mocroft, Amanda
AU - EuroSIDA in EuroCoord
PY - 2014/2/20
Y1 - 2014/2/20
N2 - Most antiretroviral drugs are metabolized by the liver; hepatic disease or liver damage as a result of hepatitis C virus (HCV) could impair this metabolism leading to an increased risk of drug toxicity. This study aimed to determine the risk of antiretroviral drug discontinuation among HCV/HIV coinfected patients.
AB - Most antiretroviral drugs are metabolized by the liver; hepatic disease or liver damage as a result of hepatitis C virus (HCV) could impair this metabolism leading to an increased risk of drug toxicity. This study aimed to determine the risk of antiretroviral drug discontinuation among HCV/HIV coinfected patients.
U2 - 10.1097/QAD.0000000000000069
DO - 10.1097/QAD.0000000000000069
M3 - Journal article
C2 - 24468998
VL - 28
SP - 577
EP - 587
JO - AIDS
JF - AIDS
SN - 1350-2840
IS - 4
ER -